{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:01:28Z","timestamp":1773676888604,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,16]]},"DOI":"10.7759\/cureus.105315","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:24:18Z","timestamp":1773671058000},"source":"Crossref","is-referenced-by-count":0,"title":["Dextromethorphan for Restless Legs Syndrome: Testing the Glutamate Theory"],"prefix":"10.7759","author":[{"given":"Melissa","family":"Khalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefany","family":"Garces Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brynn","family":"Dredla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.23247","article-title":"Restless legs syndrome. A review","volume":"335","author":"Winkelman JW","year":"2026","unstructured":"Winkelman JW, Wipper B. Restless legs syndrome. A review. JAMA. 2026, 335:703-14. 10.1001\/jama.2025.23247","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318294b3f6","article-title":"Thalamic glutamate\/glutamine in restless legs syndrome: increased and related to disturbed sleep","volume":"80","author":"Allen RP","year":"2013","unstructured":"Allen RP, Barker PB, Horsk\u00e1 A, Earley CJ. Thalamic glutamate\/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology. 2013, 80:2028-34. 10.1212\/WNL.0b013e318294b3f6","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2018.12.005","article-title":"Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport","volume":"84","author":"Ferr\u00e9 S","year":"2019","unstructured":"Ferr\u00e9 S, Quiroz C, Rea W, Guitart X, Garc\u00eda-Borreguero D. Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport. Adv Pharmacol. 2019, 84:3-19. 10.1016\/bs.apha.2018.12.005","journal-title":"Adv Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance","volume":"15","author":"Allen RP","year":"2014","unstructured":"Allen RP, Picchietti DL, Garcia-Borreguero D, et al.. Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014, 15:860-73. 10.1016\/j.sleep.2014.03.025","journal-title":"Sleep Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.10.010","article-title":"World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG)","volume":"26","author":"Ferri R","year":"2016","unstructured":"Ferri R, Fulda S, Allen RP, et al.. World Association of Sleep Medicine (WASM) 2016 standards for recording and scoring leg movements in polysomnograms developed by a joint task force from the International and the European Restless Legs Syndrome Study Groups (IRLSSG and EURLSSG). Sleep Med. 2016, 26:86-95. 10.1016\/j.sleep.2016.10.010","journal-title":"Sleep Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114158","article-title":"Brain-iron deficiency models of restless legs syndrome","volume":"356","author":"Earley CJ","year":"2022","unstructured":"Earley CJ, Jones BC, Ferr\u00e9 S. Brain-iron deficiency models of restless legs syndrome. Exp Neurol. 2022, 356:114158. 10.1016\/j.expneurol.2022.114158","journal-title":"Exp Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25104","article-title":"Targeting hypersensitive corticostriatal terminals in restless legs syndrome","volume":"82","author":"Yepes G","year":"2017","unstructured":"Yepes G, Guitart X, Rea W, et al.. Targeting hypersensitive corticostriatal terminals in restless legs syndrome. Ann Neurol. 2017, 82:951-60. 10.1002\/ana.25104","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2019.03.006","article-title":"Neurochemical features of idiopathic restless legs syndrome","volume":"45","author":"Jim\u00e9nez-Jim\u00e9nez FJ","year":"2019","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, Ag\u00fandez JA. Neurochemical features of idiopathic restless legs syndrome. Sleep Med Rev. 2019, 45:70-87. 10.1016\/j.smrv.2019.03.006","journal-title":"Sleep Med Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1400","article-title":"Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine","volume":"20 Suppl 1","author":"Ferr\u00e9 S","year":"2010","unstructured":"Ferr\u00e9 S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J Alzheimers Dis. 2010, 20 Suppl 1:S35-49. 10.3233\/JAD-2010-1400","journal-title":"J Alzheimers Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00722","article-title":"Pivotal role of adenosine neurotransmission in restless legs syndrome","volume":"11","author":"Ferr\u00e9 S","year":"2017","unstructured":"Ferr\u00e9 S, Quiroz C, Guitart X, et al.. Pivotal role of adenosine neurotransmission in restless legs syndrome. Front Neurosci. 2017, 11:722. 10.3389\/fnins.2017.00722","journal-title":"Front Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109568","article-title":"Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis","volume":"27","author":"Mogavero MP","year":"2024","unstructured":"Mogavero MP, Salemi M, Lanza G, et al.. Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis. iScience. 2024, 27:109568. 10.1016\/j.isci.2024.109568","journal-title":"iScience"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2018.12.002","article-title":"The neurophysiology of hyperarousal in restless legs syndrome: hints for a role of glutamate\/GABA","volume":"84","author":"Lanza G","year":"2019","unstructured":"Lanza G, Ferri R. The neurophysiology of hyperarousal in restless legs syndrome: hints for a role of glutamate\/GABA. Adv Pharmacol. 2019, 84:101-19. 10.1016\/bs.apha.2018.12.002","journal-title":"Adv Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200206000-00034","article-title":"Oral ketamine: a promising treatment for restless legs syndrome","volume":"94","author":"Kapur N","year":"2002","unstructured":"Kapur N, Friedman R. Oral ketamine: a promising treatment for restless legs syndrome. Anesth Analg. 2002, 94:1558-9. 10.1097\/00000539-200206000-00034","journal-title":"Anesth Analg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000150961.24747.98","article-title":"The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes","volume":"100","author":"Hara K","year":"2005","unstructured":"Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg. 2005, 100:1400-5. 10.1213\/01.ANE.0000150961.24747.98","journal-title":"Anesth Analg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01019-4","article-title":"Restless legs syndrome: contemporary diagnosis and treatment","volume":"18","author":"Gossard TR","year":"2021","unstructured":"Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics. 2021, 18:140-55. 10.1007\/s13311-021-01019-4","journal-title":"Neurotherapeutics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701606443","article-title":"Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"45","author":"Chyka PA","year":"2007","unstructured":"Chyka PA, Erdman AR, Manoguerra AS, et al.. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007, 45:662-77. 10.1080\/15563650701606443","journal-title":"Clin Toxicol (Phila)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05658-1","article-title":"Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome","volume":"12","author":"Dowsett J","year":"2022","unstructured":"Dowsett J, Didriksen M, von Stemann JH, et al.. Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome. Sci Rep. 2022, 12:1672. 10.1038\/s41598-022-05658-1","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11378-8","article-title":"Dextromethorphan exhibits anti-inflammatory and immunomodulatory effects in a murine model of collagen-induced arthritis and in human rheumatoid arthritis","volume":"7","author":"Chen DY","year":"2017","unstructured":"Chen DY, Lin CC, Chen YM, Chao YH, Yang DH. Dextromethorphan exhibits anti-inflammatory and immunomodulatory effects in a murine model of collagen-induced arthritis and in human rheumatoid arthritis. Sci Rep. 2017, 7:11353. 10.1038\/s41598-017-11378-8","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369594-dextromethorphan-for-restless-legs-syndrome-testing-the-glutamate-theory","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:24:19Z","timestamp":1773671059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369594-dextromethorphan-for-restless-legs-syndrome-testing-the-glutamate-theory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.105315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}